SCM
IDIX

Sarissa Capital Management’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Sarissa Capital Management’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,000,000
Closed -$48.2M – 16
2014
Q2 		$48.2M Sell
2,000,000
-3,050,100
-60% -$31.8M 16.39% 2
2014
Q1 		$30.5M Hold
5,050,100
– – 10.49% 4
2013
Q4 		$30.2M Buy
+5,050,100
New +$23.4M 11.31% 3

Sarissa Capital Management's IDIX Position: Q3 2014 in Review

Sarissa Capital Management sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 2,000,000 shares — an estimated $48.2M sold.

Sarissa Capital Management first reported a position in IDIX in Q4 2013 and held it in 3 quarters. The position peaked at $48.2M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Sarissa Capital Management reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Sarissa Capital Management sold 2,000,000 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $48.2M.
  • Sarissa Capital Management first reported a position in IDENIX PHARMACEUTICALS INC in Q4 2013 and held it in 3 quarters.
  • Sarissa Capital Management's IDENIX PHARMACEUTICALS INC position peaked at $48.2M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Sarissa Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.